Otolith
Otolith Labs, Inc. (trading as Otolith) is a privately held, clinical-stage medical device company headquartered at 200 Massachusetts Ave NW in Washington, D.C., founded in 2015 by Sam Owen and developing a non-invasive wearable headband — the OtoBand — that applies calibrated mechanical vibration to the vestibular system, a technique the company calls non-invasive Vestibular Resonance Therapy (nVRT) or vestibular masking, to reduce the symptoms of chronic vertigo and vestibular migraine without surgery, medication, or patient-specific calibration. The device holds an FDA Breakthrough Device designation, has been evaluated in clinical work spanning 600+ subjects, and is being studied for cybersickness in virtual reality. Otolith Labs is backed by Morningside Ventures, Mark Cuban Companies and a group of ENT physician investors. It is a physical medical device manufacturer: it publishes no public API, developer portal, SDK, or machine-readable specification, and its only web surface is a WordPress marketing, investor and clinical-trial site.
Otolith is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Healthcare, MedTech, and Wearables.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Company 1
The organization behind the API
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.